(Q51777847)

12 April 2018

title

Overcoming various comorbidities by G-CSF-primed unmanipulated BM SCT in adult patients with AML. (English)

1 reference

12 April 2018

1 reference

H-J Kim

1

1 reference

12 April 2018

W-S Min

2

1 reference

12 April 2018

B-S Cho

3

1 reference

12 April 2018

K-S Eom

4

1 reference

12 April 2018

S-Y Kim

5

1 reference

12 April 2018

Y-J Kim

6

1 reference

12 April 2018

S Lee

7

1 reference

12 April 2018

C-K Min

8

1 reference

12 April 2018

S-G Cho

9

1 reference

12 April 2018

J-W Lee

10

1 reference

12 April 2018

C-C Kim

11

1 reference

12 April 2018

language of work or name

English

0 references

publication date

9 March 2009

1 reference

12 April 2018

Bone Marrow Transplantation

published in

1 reference

12 April 2018

volume

44

1 reference

12 April 2018

issue

6

1 reference

12 April 2018

page(s)

345-351

1 reference

12 April 2018

https://scigraph.springernature.com/pub.10.1038/bmt.2009.42

exact match

0 references

cites work

A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.42

Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.42

Do G-CSF mobilized, peripheral blood-derived stem cells from healthy, HLA-identical donors really engraft more rapidly than do G-CSF primed, bone marrow-derived stem cells? No!

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.42

Successful treatment of primary refractory acute myeloid leukemia with megadose stem cell transplantation, bone marrow boost and reduced intensity conditioning avoiding chronic graft vs. host disease and severe late toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.42

G-CSF-primed haploidentical marrow transplantation without ex vivo T cell depletion: an excellent alternative for high-risk leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.42

Interpretation of interleukin-2 receptor alpha positive cells during induction chemotherapy for adult acute myelogenous leukaemia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.42

Anti-leukaemic role of acute GvHD after unrelated haematopoietic stem cell transplantation in intermediate- to high-risk acute myelogenous leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.42

Autologous stem cell transplantation using modified TAM or combination of triple-alkylating agents conditioning regimens as one of the post-remission treatments in patients with adult acute myeloid leukemia in first complete remission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.42

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.42

7 January 2021

A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G-CSF

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.42

7 January 2021

Long-term follow-up after allogeneic granulocyte colony-stimulating factor--primed bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.42

7 January 2021

Comparison of granulocyte colony-stimulating factor (G-CSF)--mobilized peripheral blood progenitor cells and G-CSF--stimulated bone marrow as a source of stem cells in HLA-matched sibling transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.42

7 January 2021

Comparative analysis of clinical outcomes after allogeneic bone marrow transplantation versus peripheral blood stem cell transplantation from a related donor in Japanese patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.42

7 January 2021

CD34+ cell dose predicts relapse and survival after T-cell-depleted HLA-identical haematopoietic stem cell transplantation (HSCT) for haematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.42

7 January 2021

A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 x 10(6) CD34+ cells/kg be considered the minimum threshold?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.42

7 January 2021

Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.42

7 January 2021

A prospective study of G-CSF primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.42

7 January 2021

Identifiers

DOI

10.1038/BMT.2009.42

1 reference

12 April 2018

1 reference

12 April 2018